Diagnostic Biomarkers in Metabolomics

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development and optimally to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.

  • Metabolite platform for validation of biomarkers
  • Biomarkers in drug development
  • Disease related biomarkers
  • Imaging biomarkers
  • Metabolomics in biomarker discovery

Related Conference of Diagnostic Biomarkers in Metabolomics

February 22-23, 2023

International Bio Summit and Expo

London, UK
April 17-18, 2023

13th World Glycobiology Congress

Rome, Italy
June 27-28, 2023

3rd Annual Summit on Advanced Bionics

Vienna, Austria
September 21-22, 2023

19th World Congress on Structural Biology

Paris, France
September 21-22, 2023

14th International Conference on Biofuels and Bioenergy

Toronto, Canada
October 23-24, 2023

27th European Biotechnology Congress

Rome, Italy
October 30-31, 2023

14th World Congress on Cell & Tissue Science

Rome, Italy

Diagnostic Biomarkers in Metabolomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in